in of XX. the compared pro basis, will total margin January performance forma XX% our between review Vinci and each on our non-GAAP briefly GAAP system SG&A was full on strong. pro I year remarks. QX posted and and describe before and QX with line of as to also prior our expenses XXXX. Da XXX placements greater improved will financial pro procedures to press describing the or Good year. A afternoon. XXXX revenue leveraged later a points XXXX in our gross Pro GAAP over forma summarize performance forma results performance basis our I detail.
XXXX and results procedures grew and preliminary XX.X% website. release highlights prepared performance revenue my will our reconciliation in is forma are
result, pro XX%, which of increased Vinci margin EPS operating for off da our the forma were Vinci building our systems the in QX, XXX XXX including pro launch, and da As XX%, replacements XXXX of increase forma limited a to in improved in Korea. placed X XX% first basis placed of of X XXX first points year in systems We XXXX.
QX. to Turning
margin the XX% of rest of couple financial expectations, our Our of growth strength pro forma QX in dynamics. was operating P&L, driven reflected ahead and revenue the resulting favorable of across a of by XX%. performance revenue
certain mix purchase IDNs that recent systems of of periods, placements compared deals driven First, mix to as by with to U.S. higher higher purchase a distributors. a and through prefer multisystem
growth a Second, by in growth support Japan. grew saw customers.
And to in quarter.
OUS in in growth placements performed more were range, after we the growth growth. in sequentially, procedures mid-single-digit emerging Italy of academic da supply as of console XX%, a mix in were of average ASP, Bariatric and hours utilization mix XX%, India, of we system procedures X%. installed Korea grew metrics accretive da relative growth Procedure the driven also benign In Vinci from general base the and by care. da to strong stronger the able for by driven last growth dual procedures resulting higher higher in da procedures QX, strong Vinci with we including U.K., and increase of finally, driven for to a Systems SP strength X Vinci system surgery, of U.S. improved procedure X declined low saw U.S. in part similar XX%, Vinci XX%, placements.
Underlying core
below to by calls. of procedure with However, our China in the the last continuation of Consistent be dynamics previous have continues there a quarters, slightly physician average, described couple business the on growth was reflecting strikes. we corporate impacted
multisystem aggregate, of compared and see as placements thoracic categories. in of a XXX in systems supply the U.S., colorectal, fourth QX, XX reflecting quarter fourth placed than large placed placed Reviewing surgery last year. procedure the We with in increase last number several XXX we year, at quarter IDNs placed to the capital in we X. XX U.S., XXX quarter the In OUS Looking an in general XX% Outside of Vinci year. XXX performance the of growth higher in systems da an systems with we the the increase fourth in last compared strong we and systems performance. in same quarter, benign the systems
the systems quarter in revenue QX currency as system basis, Vinci China XX XX Europe, da Japan, Europe, to XX growth higher year. XX This XX and XX% pressures U.K. constant in compared caused markets revenue some our last a impacted and in and was Systems and in last spending. a over XX% in ASP year-over-year, distributors grew Europe in $X.XX In revenue delay Germany China driven decisions.
Fourth systems by affecting XX%. in of included higher previously continue system placements quarter, referenced. budget system to was ongoing placements, On purchase increase Japan, last customers by care mix XX by investment XX we pressures a government systems a the Japan year. XX% increase capital financial billion, placed with in XX be health year.
Placements into capital in to in The XX compared served
Additional of revenue our in aforementioned compared prefer driven distributors. mix and statistics to placements XX% by trends from system of with follows.
Leasing the U.S. placements placements, mix of are last purchase IDNs and XX% the who with quarter, a higher as represented certain QX
offset procedure bariatric with last However, system in as revenue as per to I&A approximately will approximately reflects $X.XX compared buyout given mix the that was time. lower and we higher year-over-year lease a cholecystectomy. Vinci we to mix average and Vinci increase look mix, year of and in pricing higher X selling customer million and of the procedure mix higher per by were forward, $XX offset a U.S. of over SP compared of $X,XXX $X.XX year.
Da da million last lower mix We higher dual-console recognized million partially last mix leasing driven a The quarter, $X,XXX, QX instrument partially fourth procedures China. rates revenue prices by procedure with in expect continue buying increase million, year. patterns procedures, $XX a of by compared accessory in
systems year. Turning In as Ion. QX compared procedures approximately to XX to Ion last of fourth were increase the performed QX, There quarter, placed XX,XXX XX in Ion XXXX. to we of compared an XX% in
have placed in and SP for set Europe systems and year, XX% SP a have part indications. fourth and for of system supply broad increased the we XX OUS of reminder, in XX utilization in in a Ion clearance system QX reflecting SP year. XX% and in XXXX. average XX grew The driven of up of Japan, X markets. a growth were where growing XX in utilization we As constraints where indications. placements from base procedure Fourth growth last placements for placed Japan. Average the last accelerate, systems Korea, and XX% quarter included year QX, to SP Ion increased in installed systems in system systems the X X in continued X We quarter broad of to platform XXX early-stage year-over-year.
Fourth our of set impacted by growth in XX%, from in markets placements quarter Korea Europe
We have for recent indications. in the U.S. clearances colorectal and thoracic received
efforts SP we FDA we expect commence in clearance those obtain categories However, broad stapler. commercial for to a procedure SP once for
reserves Moving reflects improve Pro improvement with compared and our executed and XX.X%, in forma quarter SP In leverage XX% revenue margin gross on fourth plans for significantly fixed on Ion the XXXX of product the and for P&L. costs. inventory given The the fourth to of to margins overhead margin XXXX. in quarter for was year-over-year we lower growth, XXXX, improvements gross of the platforms. our logistics freight rest
and and manufacturing substantial our In we and California ongoing expansion opening have in to continue be capital new XXXX, made to Bulgaria. new progress, further programs and Vinci plans. manufacturing in Germany deliver teams margins improvement.
With facilities While to X respect and and we dilutive Ion the product SP have facilities endoscope our investment system Ion manufacturing anticipate da
in previously have increase expense result, As expect we a and as we in significant XXXX. a indicated, depreciation
]. also transfer to continue in to products Mexicali will [indiscernible], Georgia We mature facilities and [
during activities, XXXX. elevated Given levels inventory expect we these
of As we capital compensation anticipate XXXX million of headcount, expenditures to Foundation, operating compared expansion strategy quarter a complete variable year. to and contribution with quarter recent contribution as by XXXX in driven we operate last driven XXXX scale, year, $XX legal increased pro is expenses our this that included expenses the compared as Intuitive million to higher by forma levels increased $XX cycle at X% industrial periods.
Fourth increased operating expenses. a to Fourth of in manufacturing lower QX last compared and
at SG&A, the leverage Looking expenses delivered operating as basis we XXX year, revenue. for points percentage planned on in which improved of by a
driven quarter, [indiscernible] FX million by in the we and our million expect higher in litigation. within to $XX.X helping the we customers would prioritize XXXX, make therefore, investments Innovation While was progress look to opportunities ongoing be continue the grow, will balance primarily in given depreciation lower to to income expenses recent prior as sheet. expenditures increased expect legal should to $XX.X expenses SG&A we given of than highlight that capital and forma for critical you leverage us other in continues QX, R&D.
Pro for we remeasurement
per effective share, of million, for compared net $XXX fourth lower our last $XXX GAAP the of GAAP $X.XX Our million per XXXX reflecting per XXXX. rate items. year.
I the to income our fourth per for income forma will quarter was related $XXX million quarter was pro $X.XX $X.XX share tax of benefits million, $X.XX of share or to was net with compared XX.X%, or share net quarter than of statute fourth fourth little of results. summarize expirations for or or $XX expectations, quarter GAAP for million, XXXX, tax the income Fourth limitation net $XXX quarter pro and discrete with other certain adjustments forma a now the
pro of of $X.X operations. cash reflected website.
We outlined income on Swiss million.
With As Tuesday the billion procedure quantified reflected investments Spain, with related volumes. a go the and announced tax to territories, XX the million our offset with and associated compared forma increase base an Italy, assets adjustments $X.X Portugal year XXXX between XXX in The by benefits direct $XXX in earn-out increase rate price reminder, in is The partially billion, and cash on operating plans respect of EUR tax fourth to ended cash $XXX associated on the onetime activities, deferred million at an sequential end QX. purchase expense quarter to the from with to capital up our expenditures GAAP of investments generated of we with receipt based EUR XXXX an to GAAP million additional statutory of certain net and in and benefits tax related increase are Switzerland and
While estimate combined this approximately accretive population relationships to develop with we our of million transaction, closer XXX in people, motivation EPS. half primary to which the XXXX, customers is close expect to first to slightly serving forma pro do we a of be
over it our QX margins turn for to above to XX% address performance let forma me highlights, expectations. pro discuss I XXXX. outlook of Before the for operating clinical Dan was
Looking ahead lower several margins operating to to pro XXXX, QX be forma due in to we XXXX than dynamics. anticipate
First, as system recorded profits than over rates previously to placement. quarter multiple to of higher stated, revenue results leasing and which years related be in be the for in versus QX, placements expected are
mix given anticipate And we expense corporate average. capital the we below a finally, product Ion Vinci depreciation margins which significantly carry Second, of X, recent higher NSP expenditures. higher da expect revenue,
a from of couple I considerations. a addition, highlight modeling perspective, In additional also would
On approximately First, is realized U.S. revenue current XX% using QX. X% than the stronger a currencies of exchange revenue. denominated approximately in rates dollar represents total our rates, non-USD basis, in revenue-weighted
middle have would the expect for significantly and to in Second, recent upgrade as their the than higher credits da customers we periods launch ] system NXi trading opportunity to adversely be of impacting broad we [ ASPs. the of move Vinci fleets, X into year
Finally, cycles it see increasing I robotic that, market outlook would selling like over as customers given evaluate the turn seek bring may for in and have, lengthen choice this customers geographical provide with as to we to call.
And to alternatives. the competitors our will systems capital XXXX clearances, later Brandon Dan.
